HIV treatment and care systems: The way forward

AIDS

Volumn 26, Issue SUPPL.2, 2012, Pages

  Ross, David A ^a   South, Annabelle ^a,b   Weller, Ian ^b   Hakim, James ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE;

BACTERIAL INFECTION; DECENTRALIZATION; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; MENTAL HEALTH CARE; NUTRITIONAL SUPPORT; PATIENT COUNSELING; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REPRODUCTIVE HEALTH; REVIEW; SEXUAL HEALTH; SOCIOECONOMICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DELIVERY OF HEALTH CARE, INTEGRATED; DEVELOPING COUNTRIES; FEMALE; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; PREGNANCY;

EID: 84872859004     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835bde37     Document Type: Review

References (27)

1. UNAIDS, WHO, UNICEF. GLOBAL HIV/AIDS RESPONSE. Epidemic update and health sector progress towards Universal Access, 2011 Progress Report. Geneva; WHO, 2011.
2. UNAIDS. Press release. HIV treatment now reaching more than 6 million people in sub-Saharan Africa. Geneva, UNAIDS 2012. http://www.unaids.org/en/ resources/presscentre/pressreleaseandstatementarchive/2012/july/ 20120706prafricatreatment/ [Accessed on 31 July 2012].
3. Grépin KA. Efficiency considerations of donor fatigue, universal access to ARTs and health systems. Sex Transm Infect 2012; 88:75-78.
4. Munderi P, Grosskurth H, Droti B, Ross DA. What are the essential components of HIV treatment and care services in low and middle-income countries: an overview by settings and levels of the health system. AIDS 2012;this issue.
5. Kenny J, Mulenga V, Hoskins S, Scholten F, Gibb D. The needs for HIV treatment and care of children, adolescents, pregnant women and older people in low and middle-income countries. AIDS 2012;this issue.
6. Mayston R, Kinyanda E, Chishinga N, Prince M, Patel M. Mental disorder and the outcome of HIV/AIDS in low and middle income countries: a systematic review. AIDS 2012;this issue.
7. Hoskins S, Jahn A, Somi G, Semenenko I, Kirungi W, Kaleebu P, et al. Evaluating the systems used to monitor HIV populations accessing therapy and care in low and middle-income countries. AIDS 2012;this issue.
8. Hanefeld J. The impact of Global Health Initiatives at national and sub-national level - a policy analysis of their role in implementation processes of antiretroviral treatment (ART) roll-out in Zambia and South Africa. AIDS Care 2010; 22 (Suppl 1):93-102.
9. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2010 revision. Geneva, WHO. http://www.who.int/hiv/pub/arv/adult2010/en/index.html [Accessed on 7 July 2012].
10. World Health Organization. Priority Interventions: HIV/AIDS prevention, treatment and care in the health sector. WHO HIV/ AIDS Department: Geneva 2009.
11. Rajaraman D, Chishinga N, South A, Banda J. Integrating HIV services in Zambia: effectiveness, efficiency and equity? Evidence for Action Policy briefing Paper No. 2. 2009. http://www.evidence4action.org/[Accessed on 7 July 2012].
12. Legido-Quigley H, Montgomery CM, Khan P, Atun R, Fakoya A, Getahun H, Grant AD. Integrating tuberculosis and HIV services in low and middle-income countries: a systematic review. Trop Med Int Health (in press).
13. Medina Lara A, Kigozi J, Amurwon J, Muchabaiwa L, Nyanzi Wakaholi B, Mujica Mota RE, et al. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. PLoS One 2012; 7:e33672; doi:10.1371/journal.pone.0033672.
14. DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised noninferiority trial. Lancet 2010; 375:123-131
15. Lablite. 'Lablite website.' http://www.lablite.org [Accessed on 1 August 2012]
16. Larson BA, Schnippel K, Ndibongo BBA, Xulu T, Brennan A, Long L, et al. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: An evaluation of a pilot program in South Africa. J Acquir Immune Defic Syndr 2012; 61:e13-e17.
17. Rajaraman D, Palmer N. Changing roles and responses of healthcare workers in HIV treatment and care. Trop Med Int Health 2008; 13:1357-1363. (Pubitemid 352678090)
18. Wringe A, Cataldo F, Stevenson N, Fakoya A. Delivering comprehensive home-based care programmes for HIV: a review of lessons learned and challenges ahead in the era of antiretroviral therapy. Health Policy Plan 2010; 25:352-362.
19. Ferrand RA, Corbett EL, Wood R, Hargrove J, Ndhlovu CE, Cowan FM, et al. AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS 2009; 23:2039-2046.
20. Ferguson L, Lewis J, Grant AD, Watson-Jones D, Vusha S, Ong'ech JO, Ross DA. Patient attrition between diagnosis with HIV in pregnancy-related services and long-term HIV care and treatment services in Kenya: A retrospective study. J Acquir Immune Defic Syndr 2012; 60:e90-e97.
21. Ferguson L, Grant AD, Watson-Jones D, Kahawita T, Ong'ech JO, Ross DA. Linking Women who Test HIV-Positive in Pregnancy- Related Services to Long-Term HIV Care and Treatment Services: A Systematic Review. Trop Med Int Hlth 2012; 17:564-580.
22. Kinyanda E, Hoskins S, Nakku J, Nawaz S, Patel V. Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, Uganda. BMC Psychiatry 2011; 11:205.
23. Chishinga N, Kinyanda E, Weiss HA, Patel V, Ayles H, Seedat S. Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia. BMC Psychiatry 2011; 11:75.
24. Hoskins S, Weller I, Jahn A, Kaleebu P, Malyuta R, Kirungi W, et al. An appraisal of indicators used to monitor the treated population in antiretroviral programmes in low-income countries. AIDS 2010; 24:2603-2607.
25. Ba?rnighausen T, Xolo V, Cooke G. Evaluating the performance of antiretroviral treatment programs: mortality and loss to follow up. PLoS Med 2007; e298.
26. UNAIDS. Report on the Global AIDS Epidemic 2011. Geneva; UNAIDS.
27. Parkhurst J, Weller I, Kemp J. Getting research into policy, or out of practice, in HIV? Lancet 2012; 375:1414-1415.